CLINICAL
APPLICATIONS & DISEASE - AIDS
Clinical
Applications & Disease > AIDS
Contrast sensitivity
and AIDS (Summary from: Kristine Morrill, OSN Staff Writer.
Ocular Surgery News, November 1, 1991.) The use of contrast sensitivity
testing may be one of the most sensitive methods for detection of AIDS-related
diseases in HIV-positive people who are seemingly asymptomatic.
The conclusion is
being reached as a result of a general vision screening offered since
April at the Gibson Center for HIV Related Research in Houston, in which
more than 140 HIV-positive people had been tested as of press time
(this article was published in November 1991).
The data showed
that 46.8% of those tested, who were otherwise asymptomatic, had contrast
sensitivity deficits, most from various types of neuro-ophthalmological
pathology.
Breakdown of
Diseases
- 6% with abnormal
tests were found to have cytomegalovirus (CMV) retinitis.
- 4% were found
to have neuro-toxoplasmosis.
- 2% had cotton-wool
spots.
- 1% had neurolymphoma
- 21% were found
to have generalized neurological deficit.
- 10% were found
to have refractive errors.
The director of
the study at the Gibson Center, Fred Ussery III, MD, a neuro-ophthalmologist,
told Ocular Surgery News that the results were far beyond what was expected.
"I certainly
think we found things we weren't expecting to find and they center around
the apparent sensitivity of visual contrast sensitivity testing and
picking up early clinical asymptomatic CMV retinopathy," Ussery
said.
The clinic began
to incorporate contrast sensitivity testing into its protocol in 1988
to get a better look at central visual acuity after Ussery saw a number
of reports on testing.
"We work specifically
with neurological ophthalmic problems and we estimate that probably
20% to 25% of patients with AIDS will develop some type of ocular complications,"
said Kathi Redding, RN, C, CRNO, clinical director of the Gibson Center.
The longevity of
AIDS patients increases each year, said Redding, which is good news
for patients, but frequently means they will develop more numerous complications
as their immune systems weaken.
"From a standpoint
of an early screening device, I think (contrast sensitivity testing)
is incredible," Redding said. "When I started HIV nursing
seven years ago, AIDS patients lived an average of about two months.
Now we're seeing people that are seven, eight, ten years into the illness-wellness."
Clinical
Applications & Disease > AIDS